Missionpharma, officially known as Missionpharma A/S, is a leading provider of healthcare solutions headquartered in Denmark (DK). Established in 2000, the company has made significant strides in the pharmaceutical and medical supply industry, focusing on the procurement and distribution of essential medicines and medical devices across various regions, including Africa and Asia. With a commitment to improving healthcare access, Missionpharma offers a diverse range of products, including generic pharmaceuticals, surgical instruments, and diagnostic tools. Their unique approach combines quality assurance with competitive pricing, ensuring that healthcare providers receive reliable products tailored to their needs. Recognised for their dedication to social responsibility, Missionpharma has positioned itself as a trusted partner in global health initiatives, contributing to improved health outcomes in underserved communities.
How does Missionpharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Missionpharma's score of 37 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Missionpharma reported carbon emissions of approximately 305,000 kg CO2e, all of which fall under Scope 1 emissions. There were no reported emissions for Scope 2 or Scope 3. This marks an increase from 2023, when the company recorded about 273,000 kg CO2e in Scope 1 emissions. Despite the increase in emissions, Missionpharma has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of a climate pledge or formal commitments suggests that the company may still be in the early stages of developing a comprehensive climate strategy. As a global entity headquartered in Denmark (DK), Missionpharma's emissions data reflects its operational impact, but further transparency regarding future climate commitments and reduction strategies would be beneficial for stakeholders and the environment alike.
Access structured emissions data, company-specific emission factors, and source documents
2023 | 2024 | |
---|---|---|
Scope 1 | 273,000 | 000,000 |
Scope 2 | - | - |
Scope 3 | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Missionpharma is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.